Vildagliptin and Metformin Hydrochloride

Vildiabate M 1000

Vildagliptin and Metformin Hydrochloride are medications used to treat type 2 diabetes.

Vildagliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones in the body, which help to lower blood sugar levels by stimulating the release of insulin and reducing the production of glucose by the liver.

Metformin is a medication from the biguanide class that works by reducing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin, thereby reducing the amount of glucose absorbed by the intestines.

When used together, Vildagliptin and Metformin Hydrochloride can provide better control of blood sugar levels in patients with type 2 diabetes than either medication used alone. They are usually taken orally, with meals, and dosages may vary depending on individual needs.

Common side effects of Vildagliptin and Metformin Hydrochloride may include nausea, diarrhea, vomiting, abdominal pain, headache, dizziness, and hypoglycemia (low blood sugar). It is important to talk to a healthcare provider before taking these medications, especially if you have any underlying health conditions or are taking any other medications.

For further information please contact:
info@sterispharma.com